Diagnosis Of Infectious Disease Articles & Analysis: Older
9 news found
Boston: Microneedle technology, driven by high demand in dermatologic procedures and its versatile applications in drug delivery, vaccine administration, and disease diagnostics, faces challenges in its complex manufacturing process. Ongoing research and numerous products in development make this market dynamic for newcomers entering the field. “According to the latest BCC Research study, ...
” About Tuberculosis Tuberculosis, an infectious bacterial disease, is a leading cause of death worldwide, despite being preventable and often curable. ...
By relying on the immune response, rather than direct pathogen detection, the LIAISON MeMed BV test complements conventional technologies, providing actionable information and better informed antibiotic and antiviral treatment decisions, allowing for rapid and accurate diagnosis. The LIAISON MeMed BV test expands DiaSorin’s market leading menu of fully-automated, ...
ByMeMed
“Visby has shown great success as an industry leader in infectious disease diagnostics with the world’s first instrument-free, single-use PCR platform to accurately and rapidly test for serious infections,” said Cunningham. “I am honored to join the board of such an innovative company that is dedicated to demonstrating a meaningful change ...
This cooperation with NanoPin is not only of great significance for the screening and diagnosis of domestic tuberculosis and infectious diseases, but also marks the beginning of nanotechnologies in diagnostics in ...
The be.well™ platform provides individuals access to molecular testing and cloud-based analytics for rapid diagnosis and management of infectious diseases. The $6 million XPRIZE Rapid Covid Testing Competition challenged any and all innovators across the world to develop frequent, fast, cheap and easy COVID-19 screening solutions to ...
Mesa Biotech has developed the Accula System, an affordable, easy-to-use, point-of-care PCR-based testing platform for infectious disease diagnosis. The platform enables rapid, highly accurate testing at physician offices, pharmacies and other settings, providing results in 30 minutes. ...
CARB-X is awarding Vaxdyn, based in Seville, Spain, up to US$892,000, plus an additional $6.36 million if certain project milestones are met, to develop a new vaccine to prevent life-threatening drug-resistant infections, including pneumonia. Vaxdyn is the first Spanish biotech to be funded by CARB-X, a non-profit partnership investing $500 million in the development of innovative vaccines, ...
Diagnostic advances play critical roles in controlling infectious disease outbreaks, supporting prevention efforts, and improving patient treatment outcomes. ...